This brand name is authorized in Austria, Ireland.
The drug TAUROLIN contains one active pharmaceutical ingredient (API):
1
|
UNII
8OBZ1M4V3V - TAUROLIDINE
|
|
Taurolidine inhibits the formation of postoperative peritoneal adhesions, and in vitro has been shown to reduce the adherence of micro-organisms to mucosal epithelium. The chemical mode of action of taurolidine via its reactive methylol groups confers greater potency in vivo than indicated by in vitro MIC values, and also appears to preclude susceptibility to resistance mechanisms. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| TAUROLIN Solution for intraperitoneal lavage after dilution or solution for instillation | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| B05CA05 | Taurolidine | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05C Irrigating solutions → B05CA Antiinfectives |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.